Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic
Br J Dermatol
.
2023 Oct 25;189(5):509-510.
doi: 10.1093/bjd/ljad270.
Authors
Ali Shields
1
2
,
John S Barbieri
1
Affiliations
1
Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
2
Drexel University College of Medicine, Philadelphia, PA, USA.
PMID:
37503674
PMCID:
PMC10599794
DOI:
10.1093/bjd/ljad270
No abstract available
MeSH terms
Acne Vulgaris* / drug therapy
Drug Therapy, Combination
Female
Humans
Spironolactone* / therapeutic use
Substances
Spironolactone
Grants and funding
K23 AR078930/AR/NIAMS NIH HHS/United States
1K23AR078930/NH/NIH HHS/United States